Noncoding RNAs (ncRNAs) include a diverse range of RNA species, including microRNAs
(miRNAs) and long noncoding RNAs (lncRNAs). MiRNAs, ncRNAs of approximately 19–25 …

Triple-negative breast cancer (TNBC) is currently the most malignant subtype of breast
cancer without effective targeted therapies, which makes its pathogenesis an important …

The objective of this review is to elucidate the role of miRNAs in triple negative breast cancer
(TNBC). To achieve our goal, we searched databases such as PubMed, ScienceDirect …

Triple negative breast cancer (TNBC) is characterised by the lack of receptors for estrogen
(ER), progesterone (PR), and human epidermal growth factor 2 (HER2). Since it cannot be …

Triple‐negative breast cancer (TNBC) is one of the most aggressive subtypes of breast
cancer with negativity for oestrogen receptor (ER), progesterone receptor (PR) and human …

Triple-negative breast cancer (TNBC) is the most aggressive, prevalent, and distinct subtype
of breast cancer characterized by high recurrence rates and poor clinical prognosis, devoid …

Simple Summary Breast cancer is the most commonly diagnosed cancer in women today
and accounts for thousands of cancer-related deaths each year. While some breast cancer …

Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with
unfavorable outcome. It is urgent to explore novel biomarkers and potential therapeutic …

In recent years, triple‐negative breast cancer (TNBC) has emerged as the most aggressive
subtype of breast cancer and is usually associated with increased mortality worldwide. The …

Triple negative breast cancer (TNBC) is a heterogeneous disease at the molecular,
pathologic and clinical levels. To stratify TNBCs, we determined microRNA (miRNA) …